Fully automated deep learning-based localization and segmentation of the locus coeruleus in aging and Parkinson’s disease using neuromelanin-sensitive MRI - Scorecard - MDSpire

Fully automated deep learning-based localization and segmentation of the locus coeruleus in aging and Parkinson’s disease using neuromelanin-sensitive MRI

  • By

  • Max Dünnwald

  • Philipp Ernst

  • Emrah Düzel

  • Klaus Tönnies

  • Matthew J. Betts

  • Steffen Oeltze-Jafra

  • November 19, 2021

  • 0 min

Share

Clinical Scorecard: Automated Deep Learning Techniques for the Localization and Segmentation of the Locus Coeruleus in Aging and Parkinson's Disease Utilizing Neuromelanin-Sensitive MRI

At a Glance

CategoryDetail
ConditionNeurodegenerative diseases including Parkinson's disease and Alzheimer's disease
Key MechanismsNeuromelanin-sensitive MRI to visualize and segment the locus coeruleus (LC), a brainstem structure affected early in neurodegeneration
Target PopulationHealthy aging adults and Parkinson's disease patients
Care SettingNeuroimaging research and clinical neurodiagnostic settings

Key Highlights

  • The locus coeruleus is a small brainstem nucleus affected early in neurodegenerative diseases and can be visualized in vivo using neuromelanin-sensitive MRI.
  • Automated deep learning-based segmentation methods improve objectivity and reproducibility over manual segmentation, which suffers from low inter-rater agreement.
  • A novel iterative multi-scale localization network combined with multi-rater training enhances segmentation accuracy and enables fully automated extraction of imaging biomarkers such as contrast ratios.

Guideline-Based Recommendations

Diagnosis

  • Use neuromelanin-sensitive T1-weighted MRI acquisitions with high isotropic resolution (0.75 mm³, upsampled to 0.375 mm³) for LC visualization.
  • Apply automated deep learning-based localization and segmentation pipelines to identify the LC and brainstem substructures for biomarker extraction.

Management

  • Leverage automated segmentation to facilitate early detection and monitoring of neurodegenerative disease progression.
  • Utilize contrast ratios derived from segmented LC and pons regions as potential imaging biomarkers.

Monitoring & Follow-up

  • Perform longitudinal neuromelanin-sensitive MRI with automated segmentation to track LC integrity changes over time in aging and Parkinson’s disease.
  • Use multi-rater trained models to improve reliability of segmentation outcomes.

Risks

  • Manual segmentation is prone to low inter-rater reliability (Dice similarity coefficients ranging approximately 0.5 to 0.68).
  • High-resolution MRI acquisitions may reduce signal-to-noise ratio, complicating LC visualization.

Patient & Prescribing Data

Healthy aging adults (22–80 years) and Parkinson’s disease patients (48–77 years)

Automated segmentation pipelines trained on healthy aging data generalize to Parkinson’s disease subjects without fine-tuning, supporting broader applicability.

Clinical Best Practices

  • Employ neuromelanin-sensitive MRI protocols standardized for isotropic high-resolution imaging and bias field correction.
  • Use iterative multi-scale deep learning localization networks (e.g., CoRe-Unet with DSNT layer) for precise LC center of mass regression.
  • Incorporate multi-rater manual segmentations during training to improve segmentation model performance and robustness.
  • Segment brainstem substructures including pons to enable calculation of contrast ratios as imaging biomarkers.
  • Validate automated segmentation methods against expert manual delineations and post-mortem data for anatomical accuracy.

References

Original Source(s)

Related Content